Advent International announces the completion of the acquisition of Suven Pharma equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Private equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisation (CDMO) Suven Pharma. Advent acquired a 50.1% stake in Suven in December 2020 for INR 6,313 crore ($866 million) and will launch an open offer for an additional 26% of the company.
Advent acquires 50 1% in Suven Pharma, open offer for additional 26% ahead thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Advent puts in place a new team to helm Suven Pharma - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.